Alert:

We would like to inform you that Al-Khalibiya Health Center will be temporarily closed, starting from Sunday, November 9, 2025, until further notice, as part of our efforts to improve services and ensure the quality of their delivery. Services will be transferred to Al-Halah Health Center.

We would like to inform you that Al Salama Health Center will be temporarily closed from Friday, 10 October 2025 until Sunday, 12 October 2025. During this period, Al Khazan Health Center will be open instead, according to the following schedule: Friday: 7:30 AM – 12:00 PM, 17:00 PM – 22:00 PM Saturday & Sunday: 8:00 AM – 13:00 PM, 17:00 PM – 22:00 PM

We would like to inform you that Falaj Al Mualla Health Center – Umm Al Quwain has been transferred to the Initiatives of the UAE President, may Allah protect him, and is no longer under the facilities of Emirates Health Services.

We would like to inform you that radiology services at Al Madam Health Center will be temporarily suspended due to maintenance work and will be notified of any updates regarding the resumption of service later.

We would like to inform you that Al Quoz Center will operate in a trial opening phase from July 21 to 25, 2025 (Monday to Friday | 9:00 AM to 5:00 PM) and the official launch of the center is scheduled for 28th July 2025.

Your browser is outdated! For the best experience, please update to a latest version.

Al Qassimi Women’s and Children’s Hospital Achieves Medical Breakthrough in Non-Surgical Treatment of Uterine Fibroids

02 July 2024
منى كشواني 2.jpg مستشفى القاسمي للنساء والولادة والأطفال بالشارقة (1).jpg

Al Qassimi Women’s and Children’s Hospital in Sharjah, part of the Emirates Health Services (EHS), has achieved a groundbreaking milestone in the country by treating uterine fibroids using a new technique that eliminates the need for surgery. The hospital announced that it successfully treated eight patients experiencing health issues related to fibroids, including bleeding and pain, lately.

Dr. Muna Khalfan Sabt, Head of the Obstetrics and Gynecology Department at the hospital, confirmed that the uterine fibroid treatment unit utilizes a new technique recently approved by the US Food and Drug Administration for treating soft tissue tumors. This technique, known as radiofrequency ablation, has shown high efficacy and safety in treating women with uterine fibroids without the need for surgical removal. Radiofrequency ablation is a cutting-edge method for treating soft tissue tumors such as fibroids, with recent studies demonstrating its effectiveness and safety in treating various organs including the liver, kidneys, adrenal gland, thyroid gland, breasts, bones, and uterus.

Dr. Muna explained that uterine fibroid removal using radiofrequency is a form of thermal ablation that gradually shrinks fibroid size without the need for surgery or exposure to serious side effects. She emphasized that this medical procedure is characterized by its effectiveness, safety, and ability to treat uterine fibroids while preserving uterine health and integrity. Women undergoing this procedure can leave the hospital on the same day and resume their normal activities within about five days.

Dr. Mona Kashwani, Specialist in Gynecological Diseases and Robotic Surgery at the hospital, explained that uterine fibroids are benign and common tumors that affect the uterine muscle, with 30% of women experiencing them. These fibroids cause various symptoms such as bleeding, pain, fertility issues, and recurrent miscarriages. She highlighted that uterine fibroids can impact vital organs like the urinary system and kidneys at advanced stages, and can lead to complications during pregnancy. Therefore, timely diagnosis and treatment are recommended.

The adoption of modern radiofrequency ablation technology underscores the hospital's commitment to providing optimal medical care to patients. This technology stands out as the only one not requiring surgical intervention. The hospital has integrated this unique technique into its existing procedures for treating uterine fibroids, which include open surgery, robot-assisted removal, and uterine artery embolization. This achievement is a result of the collaborative efforts of the hospital's multidisciplinary team and reflects the substantial support provided by EHS in equipping its facilities with cutting-edge, high-quality medical technologies.

Do you think this content is helpful?

Have you used our services at our service center or digitally recently?